title: Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines.
abstract: APE1/Ref-1 is a main regulator of cellular response to oxidative stress via DNA-repair function and co-activating activity on the NF-κB transcription factor. APE1 is central in controlling the oxidative stress-based inflammatory processes through modulation of cytokines expression and its overexpression is responsible for the onset of chemoresistance in different tumors including hepatic cancer. We examined the functional role of APE1 overexpression during hepatic cell damage related to fatty acid accumulation and the role of the redox function of APE1 in the inflammatory process. HepG2 cells were stably transfected with functional and non-functional APE1 encoding plasmids and the protective effect of APE1 overexpression toward genotoxic compounds or FAs accumulation, was tested. JHH6 cells were stimulated with TNF-α in the presence or absence of E3330, an APE1 redox inhibitor. IL-8 promoter activity was assessed by a luciferase reporter assay, gene expression by Real-Time PCR and cytokines (IL-6, IL-8, IL-12) levels measured by ELISA. APE1 over-expression did not prevent cytotoxicity induced by lipid accumulation. E3330 treatment prevented the functional activation of NF-κB via the alteration of APE1 subcellular trafficking and reduced IL-6 and IL-8 expression induced by TNF-α and FAs accumulation through blockage of the redox-mediated activation of NF-κB. APE1 overexpression observed in hepatic cancer cells may reflect an adaptive response to cell damage and may be responsible for further cell resistance to chemotherapy and for the onset of inflammatory response. The efficacy of the inhibition of APE1 redox activity in blocking TNF-α and FAs induced inflammatory response opens new perspectives for treatment of inflammatory-based liver diseases.
authors: Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy.
authors: Laura
authors: L
authors: Cesaratto
authors: Erika
authors: E
authors: Codarin
authors: Carlo
authors: C
authors: Vascotto
authors: Antonio
authors: A
authors: Leonardi
authors: Mark R
authors: MR
authors: Kelley
authors: Claudio
authors: C
authors: Tiribelli
authors: Gianluca
authors: G
authors: Tell
mesh_terms: D016227:Benzoquinones / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase / Q000235:genetics / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D056945:Hep G2 Cells; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis* / Q000235:genetics; D008113:Liver Neoplasms / Q000235:genetics / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D011401:Promoter Regions, Genetic; D011422:Propionates / Q000494:pharmacology*; D015533:Transcriptional Activation / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D016227:Benzoquinones; D005227:Fatty Acids; D016209:Interleukin-8; D016328:NF-kappa B; D011422:Propionates; D014409:Tumor Necrosis Factor-alpha; C075569:E 3330; C085108:APEX1 protein, human; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase
references: Hepatogastroenterology. 1990 Oct;37(5):457-60
references: 1701409
references: Cytokine. 2009 Jun;46(3):359-69
references: 19376732
references: Mol Cell Biol. 2009 Apr;29(7):1834-54
references: 19188445
references: Hepatology. 2003 Feb;37(2):343-50
references: 12540784
references: J Interferon Cytokine Res. 1999 May;19(5):429-38
references: 10386854
references: Exp Hematol. 2010 Dec;38(12):1178-88
references: 20826193
references: Anticancer Res. 2011 Feb;31(2):379-85
references: 21378315
references: Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H804-12
references: 12730053
references: Gastroenterology. 2007 Jun;132(7):2601-4
references: 17570232
references: J Hepatol. 2007 Apr;46(4):708-18
references: 17275126
references: Crit Care Med. 2005 Dec;33(12 Suppl):S466-7
references: 16340423
references: Mol Cancer Ther. 2011 Sep;10(9):1698-708
references: 21700832
references: Mol Carcinog. 2007 Feb;46(2):91-9
references: 17013835
references: Mol Cell. 2005 Feb 4;17(3):463-70
references: 15694346
references: Antioxid Redox Signal. 2009 Mar;11(3):651-68
references: 18715143
references: Curr Mol Pharmacol. 2012 Jan;5(1):36-53
references: 22122463
references: Curr Biol. 2005 Feb 8;15(3):R99-R102
references: 15694301
references: World J Gastroenterol. 2005 Oct 28;11(40):6258-61
references: 16419152
references: Mayo Clin Proc. 1980 Jul;55(7):434-8
references: 7382552
references: J Pharmacol Exp Ther. 1993 Aug;266(2):1085-90
references: 8394904
references: Mol Cancer Res. 2007 Jan;5(1):61-70
references: 17259346
references: Mutat Res. 2008 May 10;641(1-2):43-7
references: 18423498
references: Methods Enzymol. 2002;353:81-8
references: 12078530
references: Br J Cancer. 1987 Sep;56(3):279-85
references: 3663476
references: Curr Med Chem. 2011;18(7):1079-84
references: 21254970
references: J Biol Chem. 1990 Dec 5;265(34):21128-33
references: 2250017
references: Antioxid Redox Signal. 2009 Mar;11(3):601-20
references: 18976116
references: Nature. 1979 Dec 6;282(5739):615-6
references: 233137
references: Antioxid Redox Signal. 2011 Apr 15;14(8):1387-401
references: 20874257
references: J Pharmacol Exp Ther. 1992 Jul;262(1):145-50
references: 1625194
references: Mol Cancer Ther. 2008 Jul;7(7):2012-21
references: 18645011
references: J Immunol. 2006 Dec 1;177(11):7990-9
references: 17114472
references: Trends Mol Med. 2008 Feb;14(2):72-81
references: 18218340
references: Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4120-5
references: 15738389
references: Biochemistry. 2011 Dec 6;50(48):10540-9
references: 22032234
references: Antioxid Redox Signal. 2009 Mar;11(3):621-38
references: 18715144
references: Free Radic Biol Med. 2012 Jul 15;53(2):237-48
references: 22580151
references: Mol Biol Cell. 2012 Oct;23(20):4079-96
references: 22918947
references: J Cell Biol. 1985 Mar;100(3):965-73
references: 3972906
references: Mol Biol Cell. 2011 Oct;22(20):3887-901
references: 21865600
references: Diabetes. 2005 Dec;54(12):3458-65
references: 16306362
references: Hepatology. 2002 Apr;35(4):964-6
references: 11915046
references: Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95
references: 17560642
references: Hepatology. 2001 Dec;34(6):1158-63
references: 11732005
references: Clin Sci (Lond). 2004 Jun;106(6):635-43
references: 14720121
references: DNA Repair (Amst). 2009 Nov 2;8(11):1273-82
references: 19726241
references: Cell Mol Life Sci. 2010 Nov;67(21):3569-72
references: 20706767
references: Mol Med. 2007 Jan-Feb;13(1-2):89-96
references: 17515960
references: Gastroenterology. 2005 Nov;129(5):1663-74
references: 16285964
references: Proteomics. 2009 Feb;9(4):1058-74
references: 19180539
references: Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84
references: 15706084
references: Cancer Res. 1982 Sep;42(9):3858-63
references: 6286115
references: Nucleic Acids Res. 2005 Jun 07;33(10):3303-12
references: 15942031
references: PLoS One. 2012;7(10):e47462
references: 23094050
references: Hepatogastroenterology. 2005 Sep-Oct;52(65):1549-53
references: 16201116
references: BMC Gastroenterol. 2012 Mar 01;12:20
references: 22380754
references: J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98
references: 20504914
references: Hepatology. 2007 Sep;46(3):823-30
references: 17680645
references: Prog Nucleic Acid Res Mol Biol. 2001;68:41-54
references: 11554312
references: J Gastrointestin Liver Dis. 2010 Dec;19(4):415-23
references: 21188334
references: Cell Mol Life Sci. 2010 Nov;67(21):3589-608
references: 20706766
references: Biochemistry. 2011 Jan 11;50(1):82-92
references: 21117647